JP2019506396A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506396A5
JP2019506396A5 JP2018538137A JP2018538137A JP2019506396A5 JP 2019506396 A5 JP2019506396 A5 JP 2019506396A5 JP 2018538137 A JP2018538137 A JP 2018538137A JP 2018538137 A JP2018538137 A JP 2018538137A JP 2019506396 A5 JP2019506396 A5 JP 2019506396A5
Authority
JP
Japan
Prior art keywords
composition according
composition
cell
wound
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506396A (ja
JP6918003B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/017848 external-priority patent/WO2017127123A1/en
Publication of JP2019506396A publication Critical patent/JP2019506396A/ja
Publication of JP2019506396A5 publication Critical patent/JP2019506396A5/ja
Application granted granted Critical
Publication of JP6918003B2 publication Critical patent/JP6918003B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538137A 2016-01-21 2016-02-12 創傷治癒のための幹細胞 Expired - Fee Related JP6918003B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662281334P 2016-01-21 2016-01-21
US62/281,334 2016-01-21
PCT/US2016/017848 WO2017127123A1 (en) 2016-01-21 2016-02-12 Stem cells for wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020116882A Division JP2020172536A (ja) 2016-01-21 2020-07-07 創傷治癒のための幹細胞

Publications (3)

Publication Number Publication Date
JP2019506396A JP2019506396A (ja) 2019-03-07
JP2019506396A5 true JP2019506396A5 (enExample) 2019-04-18
JP6918003B2 JP6918003B2 (ja) 2021-08-11

Family

ID=59360064

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018538137A Expired - Fee Related JP6918003B2 (ja) 2016-01-21 2016-02-12 創傷治癒のための幹細胞
JP2020116882A Withdrawn JP2020172536A (ja) 2016-01-21 2020-07-07 創傷治癒のための幹細胞
JP2022129977A Pending JP2022163207A (ja) 2016-01-21 2022-08-17 創傷治癒のための幹細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020116882A Withdrawn JP2020172536A (ja) 2016-01-21 2020-07-07 創傷治癒のための幹細胞
JP2022129977A Pending JP2022163207A (ja) 2016-01-21 2022-08-17 創傷治癒のための幹細胞

Country Status (11)

Country Link
US (2) US10967006B2 (enExample)
EP (1) EP3405566B1 (enExample)
JP (3) JP6918003B2 (enExample)
KR (1) KR20180102661A (enExample)
CN (1) CN108884437A (enExample)
AU (2) AU2016387339B2 (enExample)
CA (1) CA3012330A1 (enExample)
HK (1) HK1256413A1 (enExample)
NZ (1) NZ745530A (enExample)
SG (2) SG10201914102UA (enExample)
WO (1) WO2017127123A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG185526A1 (en) 2010-05-12 2012-12-28 Abt Holding Co Modulation of splenocytes in cell therapy
CA2909267C (en) 2013-04-12 2022-10-25 Saverio LA FRANCESCA Improving organs for transplantation
WO2017127123A1 (en) * 2016-01-21 2017-07-27 Abt Holding Company Stem cells for wound healing
KR102188572B1 (ko) * 2017-09-25 2020-12-09 사회복지법인 삼성생명공익재단 뇌척수액을 포함하는 줄기세포 투여 제형 및 그의 제조방법
US20220117491A1 (en) * 2020-01-23 2022-04-21 Precision Healing, Inc. Multispectral sample analysis using fluorescence signatures
US20240389931A1 (en) * 2020-01-23 2024-11-28 Precision Healing LLC Wound care diagnosis with fluorescence signatures
US20240245346A1 (en) * 2020-01-23 2024-07-25 Precision Healing, Inc. Image analysis using skin wound factors
AU2023415952A1 (en) 2022-12-27 2025-07-24 AVITA Medical Americas, LLC System for automated preparation of a regenerative epidermal suspension and related methods of use

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US7037721B1 (en) 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
AU2882992A (en) 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5766951A (en) 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US6037174A (en) 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
GB9502022D0 (en) 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US6653134B2 (en) 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
WO1998059035A2 (en) 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
RU2272839C2 (ru) 1998-11-09 2006-03-27 Консорцио Пер Ла Джестионе Дель Чентро Ди Биотекнолоджие Аванцате Бессывороточная среда для культуры клеток, используемых для реконструкции костных и хрящевых сегментов (варианты)
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050169896A1 (en) 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
US8609412B2 (en) 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
HK1049350B (en) 1999-08-05 2012-01-27 Abt Holding Company Multipotent adult stem cells and methods for isolation
US7927587B2 (en) 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
WO2005113748A2 (en) 2004-04-21 2005-12-01 Regents Of The University Of Minnesota Mapc generation of lung tissue
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
WO2005056026A1 (en) 2003-12-04 2005-06-23 Regents Of The University Of Minnesota Compositions and methods for the treatment of lysosomal storage disorders
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
EP2333049A1 (en) 1999-09-24 2011-06-15 ABT Holding Company Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2001021767A2 (en) 1999-09-24 2001-03-29 Morphogen Pharmaceuticals, Inc. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2001039784A1 (en) 1999-12-06 2001-06-07 The General Hospital Corporation Pancreatic stem cells and their use in transplantation
WO2001062901A2 (en) 2000-02-26 2001-08-30 Artecel Sciences, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
US20020061587A1 (en) 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
US7560280B2 (en) 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
KR100915483B1 (ko) 2000-12-06 2009-09-03 로버트 제이 하리리 태반 줄기 세포의 회수 방법
JP2004528021A (ja) 2001-02-14 2004-09-16 アンスロジェネシス コーポレーション 分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
IL157332A0 (en) 2001-02-14 2004-02-19 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US7056738B2 (en) 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
KR100449141B1 (ko) 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법
DE60232585D1 (de) 2001-04-24 2009-07-23 Dolores Baksh Vorläuferzellpopulationen, deren expansion und die entstehung von nicht-hämatopoetischen zelltypen daraus
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US7169610B2 (en) 2002-01-25 2007-01-30 Genzyme Corporation Serum-free media for chondrocytes and methods of use thereof
US20060228798A1 (en) 2002-11-27 2006-10-12 Catherine Verfaillie Homologous recombination in multipotent adult progenitor cells
CA2809195C (en) 2003-04-01 2014-05-20 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
US20040235165A1 (en) 2003-05-19 2004-11-25 Darwin Prockop In vitro differentiation of adult stem cells
US8192348B2 (en) 2003-07-01 2012-06-05 Regents Of The University Of Minnesota Engineered blood vessels
US8426200B2 (en) 2003-07-02 2013-04-23 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
CN1845987A (zh) 2003-08-29 2006-10-11 明尼苏达大学董事会 肾来源的干细胞及其分离、分化和使用方法
US7794706B2 (en) 2003-10-14 2010-09-14 Medivas, Llc Bioactive wound dressings and implantable devices and methods of use
WO2005085428A1 (en) 2004-03-05 2005-09-15 Davies John E Serum-free suspension culture system for mesenchymal progenitor cells
EP2824175B2 (en) 2004-03-22 2020-10-28 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
WO2006047743A2 (en) 2004-10-26 2006-05-04 Regents Of The University Of Minnesota Swine multipotent adult progenitor cells
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
EP2428563A1 (en) 2005-02-10 2012-03-14 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
AU2005331559B2 (en) 2005-05-05 2012-04-19 Regents Of The University Of Minnesota Use of NK cell inhibition to facilitate persistence of engrafted MHC-I negative cells
AU2005331534B2 (en) * 2005-05-05 2011-12-08 Regents Of The University Of Minnesota Use of MAPC or progeny therefrom to populate lymphohematopoietic tissues
US20080194021A1 (en) 2005-07-29 2008-08-14 Mays Robert W Use of a Gsk-3 Inhibitor to Maintain Potency of Culture Cells
WO2007117262A2 (en) 2005-07-29 2007-10-18 Athersys, Inc. Culture of non-embryonic cells at high cell density
EP1941032A2 (en) 2005-10-14 2008-07-09 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
US20220110982A1 (en) 2005-11-09 2022-04-14 Abt Holding Company Mapc treatment of brain injuries and diseases
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
EP2392339A1 (en) 2006-01-23 2011-12-07 Athersys, Inc. MAPC Therapeutics without adjunctive immunosuppressive treatment
AU2007321928A1 (en) 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
EP2167045B1 (en) * 2007-06-08 2017-08-09 University of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
CN101978047A (zh) 2008-01-18 2011-02-16 明尼苏达大学董事会 干细胞聚集体及制备和使用方法
EP2260096A4 (en) 2008-02-29 2013-07-17 Univ New York State Res Found METHOD FOR THE ADMINISTRATION OF PHYSICAL IRRITATION IN CELLS
US20110212062A1 (en) 2008-03-27 2011-09-01 Neostem, Inc. Compositions and methods using stem cells in cutaneous wound healing
EP2294185A2 (en) 2008-05-08 2011-03-16 Coretherapix Slu Multipotent adult stem cell population
US9382514B2 (en) 2008-06-20 2016-07-05 Escape Therapeutics, Inc. Compositions comprising mesenchymal stem cell-derived fibroblasts
SG193847A1 (en) 2008-09-04 2013-10-30 Abt Holding Co Use of stem cells to prevent neuronal dieback
WO2010049752A1 (en) 2008-10-31 2010-05-06 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
CA2768573C (en) 2009-07-21 2020-09-15 Abt Holding Company A method for constructing a cell bank and a method for drug discovery
CN104962512B (zh) 2009-07-21 2022-09-09 Abt控股公司 干细胞用于减少白细胞外渗的用途
US20120219572A1 (en) 2009-11-12 2012-08-30 Prockop Darwin J Spheroidal Aggregates of Mesenchymal Stem Cells
CA2781194A1 (en) 2009-11-19 2011-05-26 Regents Of The University Of Minnesota Reducing inflammation using cell therapy
US20150010610A1 (en) 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
WO2011106476A1 (en) 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
US20110206647A1 (en) 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
SG10201501402UA (en) 2010-02-25 2015-04-29 Abt Holding Co Modulation of macrophage activation
CN102198156A (zh) 2010-03-26 2011-09-28 傅毓秀 用于治疗皮肤创伤之医药组合物
SG185526A1 (en) 2010-05-12 2012-12-28 Abt Holding Co Modulation of splenocytes in cell therapy
WO2011143411A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy for traumatic brain injury
US9090878B2 (en) 2010-06-17 2015-07-28 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
US9682105B2 (en) 2010-07-14 2017-06-20 University Of Southern California Methods of promoting wound healing and attenuating contact hypersensitivity with gingiva-derived mesenchymal stem cells
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
CN103237886B (zh) 2010-08-24 2018-10-30 明尼苏达大学董事会 细胞集合体的非静态悬浮培养
US9388388B2 (en) 2011-01-31 2016-07-12 Katholieke Universiteit Leuven Methods for making cells with an extra-embryonic endodermal precursor phenotype
SG10201914092XA (en) 2011-06-06 2020-03-30 ReGenesys BVBA Expansion of stem cells in hollow fiber bioreactors
CA2909267C (en) 2013-04-12 2022-10-25 Saverio LA FRANCESCA Improving organs for transplantation
EP2992088B1 (en) 2013-04-30 2019-08-21 Katholieke Universiteit Leuven Cell therapy for myelodysplastic syndromes
CN105408470B (zh) 2013-06-24 2020-05-05 南加利福尼亚大学 间充质干细胞的组合物
WO2015017772A1 (en) * 2013-08-01 2015-02-05 Parcell Laboratories, Llc Stem cell-based preparations and methods for dermal and connective tissue reconstruction and rejuvenation
US20160175485A1 (en) 2013-08-27 2016-06-23 The Regents Of The University Of California Combination therapy to promote wound healing
US20160069903A1 (en) 2014-09-10 2016-03-10 Fundació Institute De Ciències Foròniques Method for detecting cells
US20160326494A1 (en) 2015-05-05 2016-11-10 Katholieke Universiteit Leuven Methods for Pancreatic Islet Transplantation
WO2017062035A1 (en) 2015-10-09 2017-04-13 Abt Holding Company Methods for enhancing proliferation of t regulatory cells
WO2017127123A1 (en) * 2016-01-21 2017-07-27 Abt Holding Company Stem cells for wound healing
US20200246390A1 (en) 2019-02-01 2020-08-06 Abt Holding Company Multipotent adult projenitor cells for treatment of ich

Similar Documents

Publication Publication Date Title
JP2019506396A5 (enExample)
Golchin et al. The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review
Duscher et al. Stem cells in wound healing: the future of regenerative medicine? A mini-review
Mazini et al. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs)
Yu et al. Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds
Eom et al. Mesenchymal stem cell therapy for cirrhosis: present and future perspectives
Sun et al. The healing effects of conditioned medium derived from mesenchymal stem cells on radiation-induced skin wounds in rats
Malliaras et al. Cardiac cell therapy: where we've been, where we are, and where we should be headed
Karantalis et al. Use of mesenchymal stem cells for therapy of cardiac disease
Peltzer et al. Mesenchymal stromal cells based therapy in systemic sclerosis: rational and challenges
Zou et al. Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs) potential role in healing cutaneous chronic wounds
van de Ven et al. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration
Carrade et al. Immunomodulation by mesenchymal stem cells in veterinary species
Mizuno et al. Concise review: adipose‐derived stem cells as a novel tool for future regenerative medicine
Marigo et al. The immunomodulatory properties of mesenchymal stem cells
Kuroda et al. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine
Yang et al. Potential application of adipose-derived stem cells and their secretory factors to skin: discussion from both clinical and industrial viewpoints
Jeong et al. Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands
Sharma et al. Translational products of adipose tissue-derived mesenchymal stem cells: Bench to bedside applications
Oh et al. Transplantation of an adipose stem cell cluster in a spinal cord injury
Anudeep et al. Advancing regenerative cellular therapies in non-scarring alopecia
Morigi et al. Cell therapy for kidney injury: different options and mechanisms-mesenchymal and amniotic fluid stem cells
Li et al. Mesenchymal stem cell–based therapy for nonhealing wounds: today and tomorrow
Ko et al. The role of stem cells in cutaneous wound healing: what do we really know?
Lewis Stem cell application in acute burn care and reconstruction